It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
A good retirement savings plan helps you accumulate wealth for the future. Discover strategies to maximize your savings for retirement.
20,039 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
When two tech giants renew a crucial chip deal, markets react fast. Discover how the Broadcom collaboration could sha...
A marquee Bitcoin treasury deal tied to Adam Back’s 30,021 bitcoin is undergoing a financing overhaul as key backers ...
Public zoning records can be helpful for planning, but they also attract scammers. This article explains how those de...
Two unevenly matched tech players—Amplitude and Agilysys—show how top-line growth and margins shape investor expectat...
Chipotle launches its first Monterrey location with Alsea, kicking off a broader push into Mexico. The move tests wal...
A suspicious phone call claiming a court order pulled a Maryland woman into a tense sting. The scam fell apart throug...
As AI partnerships captivate the market, UiPath shares edged higher amid broader tech weakness. This look at stock ma...
Christopher Nolan delivers a blockbuster opening for The Odyssey, outperforming Oppenheimer and marking his best star...
In a year of sharp rotation, the Vanguard FTSE DEVELOPED Markets ETF ex US is outperforming the S&P 500—yet the decad...
Massive AI budgets are on the horizon. This article breaks down who will spend the most, why the opportunity matters,...
When a renowned activist investor signals a bold AI bet, markets take notice. Explore how billionaire Bill Ackman bet...